Singulomics, established in New York in 2016, is a privately-held biotechnology company that aims to transform single-cell omics research and unlock its many applications in biology and medicine. Building on the unmatched expertise in single-cell genomics, transcriptomic, and epigenomics developed since the mid-2000s at Albert Einstein College of Medicine, we develop and provide high-quality, innovative single-cell and spatial multiomics services to academic and industrial communities around the world.
Company Details
- Employees
- 4
- Address
- 1300 Morris Park Avenue, Forchheimer Building, Room 726, Bronx,new York 10461,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://singulomics.com/
- Keywords
- Follow.
- HQ
- Bronx, New York
Singulomics Corporation Questions
Singulomics Corporation's website is https://singulomics.com/
Singulomics Corporation's LinkedIn profile is https://www.linkedin.com/company/singulomics
Singulomics Corporation has
4 employees.
View email and phone details for 4
employees at Singulomics Corporation.
Singulomics Corporation's industry is
Biotechnology Research
Singulomics Corporation's top competitors are
Overt Bio,
Autonomous Therapeutics,
Singular Genomics,
Atlasxomics Inc.,
Beechtree Molecular Llc,
Enzo Life Sciences, Inc.,
Novogene America,
Pinion Immunotherapeutics,
Invitro Cell Research, Llc,
The New York Stem Cell Foundation Research Institute.
Singulomics Corporation's categories are Biotechnology Research
